Esperion Therapeutics – US29664WAB19
This domestic bond is deemed as a ‘security’ for ISA qualification purposes. To qualify for ISA inclusion, either the security or the shares in the issuing company need to be listed on a recognised stock exchange or admitted to trading on a recognised stock exchange in the European Economic Area (EEA) or the UK (see ISA Guidance https://www.gov.uk/guidance/stocks-and-shares-investments-for-isa-managers#compsecur ). In this case, evidence suggests, the shares in the issuing company (Esperion Therapeutics – US29664W1053) are listed/traded on recognised stock exchange’s so on that basis, the security should qualify for stocks & shares ISA inclusion.
See links below.
Domestic bonds: Esperion Therapeutics, 4% 15nov2025, USD (Conv.) (US29664WAB19)